Management of Peripheral Artery Disease in Hemodialysis Patients

Diagnostic Considerations

The American College of Cardiology recommends that hemodialysis patients with bilateral calf pain during walking and at rest require urgent evaluation for peripheral artery disease (PAD) with immediate ankle-brachial index (ABI) testing, as this presentation suggests critical limb ischemia (CLI) or severe PAD—both life-threatening conditions in dialysis patients that demand rapid vascular assessment and intervention 1, 2, 3
Pain at rest, especially nocturnal pain relieved by leg dependency, is pathognomonic for severe arterial insufficiency and CLI in hemodialysis patients 3
The presence of multiple absent pulses dramatically increases the likelihood of confirmed PAD in hemodialysis patients 2
Examine for dependent rubor, elevation pallor, absent pulses, cool skin, or nonhealing wounds—all indicating advanced ischemia in hemodialysis patients 1, 2

The American College of Cardiology recommends palpating all four lower extremity pulses bilaterally (femoral, popliteal, dorsalis pedis, posterior tibial) and grading as: 0=absent, 1=diminished, 2=normal, 3=bounding in hemodialysis patients 1, 2
Auscultate for femoral bruits indicating proximal stenosis in hemodialysis patients 1, 2

Obtain ABI immediately as the primary diagnostic test for PAD in hemodialysis patients 2, 4
If ABI is normal but symptoms persist, perform exercise ABI testing in hemodialysis patients 4
In dialysis patients, ABI may be falsely elevated due to calcified vessels; if ABI >1.4, obtain toe-brachial index (TBI) or transcutaneous oxygen pressure (TcPO2) 2

Vascular claudication: Pain with consistent onset during activity, quick relief with rest (<10 minutes), bilateral calf location suggests tibial/popliteal disease in hemodialysis patients 1, 4
Venous claudication: Tight, bursting pain affecting entire leg, subsides slowly, relieved by elevation—history of deep vein thrombosis in hemodialysis patients 1

If CLI is confirmed (rest pain + ABI <0.4 or tissue loss), plan semi-urgent revascularization as untreated CLI leads to major amputation within 6 months and 25-35% one-year mortality in hemodialysis patients 3
Initiate antiplatelet therapy (aspirin or clopidogrel) immediately in hemodialysis patients with CLI 3
Start high-intensity statin therapy in hemodialysis patients with CLI 3
Aggressive risk factor modification: smoking cessation, diabetes control, hypertension management in hemodialysis patients with PAD 1, 2
Antiplatelet and statin therapy in hemodialysis patients with PAD 1, 2
Supervised exercise therapy (if feasible given dialysis schedule) in hemodialysis patients with PAD 1, 2
Consider cilostazol if no heart failure in hemodialysis patients with PAD 1, 2
Revascularization if symptoms are lifestyle-disabling despite medical therapy in hemodialysis patients with PAD 1, 6

Do not delay vascular assessment assuming pain is musculoskeletal—dialysis patients have 2-4 times higher PAD prevalence than the general population 1, 4
Do not rely solely on ABI in dialysis patients; falsely elevated values from medial arterial calcification can mask severe disease 2
Recognize that only one-third of PAD patients have typical claudication; atypical symptoms including rest pain are common in hemodialysis patients 1, 4
Understand that short-term cardiovascular mortality risk markedly increases once PAD is diagnosed in dialysis patients—this is not a benign condition 1, 4